antibodies

Defenses against SARS-CoV-2 variantsOur key defense against the COVID-19 pandemic is neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus elicited by natural infection or vaccination. Recent…

AbstractThe spillover of animal coronaviruses (aCoVs) to humans has caused SARS, MERS, and COVID-19. While antibody responses displaying cross-reactivity between SARS-CoV-2 and seasonal/common cold human coronaviruses (hCoVs) have been…

Boosterism could save livesPostinfection immune protection against severe acute respiratory syndrome coronavirus 2 reinfection is not fully understood. It will be devastating if waves of new variants emerge that undermine natural immune…

The recent results (1) from the Antibody Mediated Prevention (AMP) study are a landmark in AIDS research. They show that a broadly neutralizing antibody (bnAb) can protect humans against infection with sensitive strains of HIV. BnAbs,…